pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

$TAKTAKEDA PHARMACEUTICAL CO LTD

$TAK17.55+0.57%
Tokyo, JPupdated 18h ago

The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines.

SEC EDGAR ↗Yahoo Finance ↗
community read0 votes

🐶 often sniffed alongside

top 5
  • tagOncology2 co-mentions · 1 sources
  • company$TKPHFTAKEDA PHARMACEUTICAL CO LTD1 co-mentions · 1 sources
  • drugCABOMETYX1 co-mentions · 1 sources
  • drugCOMETRIQ1 co-mentions · 1 sources
  • drugcabozantinib s-malate1 co-mentions · 1 sources
pipeline
16
marketed
2
phase 3
6
catalysts ytd
5
approvals ytd
0
recalls ytd
1

Pipeline(16)

view full pipeline →
pipeline depth16 products
Preclinical: 2Phase 2: 5Phase 3: 6Marketed: 2pre_registration: 1
2Preclinical5Phase 26Phase 32Marketed1pre_registration
Marketed
Vyvanse
ADHD, binge eating disorder
Marketed
ponatinib hydrochloride
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…
Bcr/Abl fusion protein
Phase 3
(coagulation factor II (human) + coagulation factor VII (human) + coagulation factor IX (human) + coagulation factor X (human) + Protein C (human))
Blood Coagulation
Phase 3
TAK-881
Primary Immune Deficiency (PID)
Phase 3
elritercept
Anemia
Phase 3
mezagitamab
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytope…
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1
Phase 3
vedolizumab
Crohn's Disease (Regional Enteritis)
Integrin alpha-4/beta-7
Phase 3
zasocitinib
Plaque Psoriasis (Psoriasis Vulgaris)
Phase 2
TAK-101
Celiac Disease
Phase 2
TAK-360
Type 2 Narcolepsy (Narcolepsy without Cataplexy)
Phase 2
alpha-1 proteinase inhibitor (human)
Lung Transplant Rejection
Neutrophil elastase
Phase 2
arcotatug tavatecan
Pancreatic Ductal Adenocarcinoma

📅 Upcoming

Oct 29, 2026
earnings
$TAK17.55+0.57%
in 3mo
TAKEDA PHARMACEUTICAL CO LTD earnings
TAKEDA PHARMACEUTICAL CO LTD
→

🕒 Recent(90d)

earnings (2)
Jul 30, 2026
earnings
$TAK17.55+0.57%
12d ago
TAKEDA PHARMACEUTICAL CO LTD earnings
TAKEDA PHARMACEUTICAL CO LTD
→
May 13, 2026
earnings
$TAK17.55+0.57%
3mo ago
TAKEDA PHARMACEUTICAL CO LTD earnings
TAKEDA PHARMACEUTICAL CO LTD
→
view all catalysts →
🐶 Hiring Signal
next earnings Oct 29, 2026
1,634 open roles at TAKEDA PHARMACEUTICAL CO LTD →

Where TAKEDA PHARMACEUTICAL CO LTD is staffing up — a leading indicator of pipeline and commercial priorities.

therapeutic areaDermatology 142Immunology & Inflammation 66Oncology 60Rare Disease 37Cardiovascular 26CNS / Neuroscience 24
departmentRegulatory 152Business Development & Sales 84IT & Engineering 58Commercial 53Medical Affairs 46Manufacturing / CMC 39

News

no news has mentioned this company yet
identifiers
ticker
$TAK
SEC CIK
0001395064
country
JP
source
sec_tickers
top tags
Immunology3Oncology3ALS1COPD1Epilepsy1
mentioned in
0news items
entity-linker matched
Data sources
SEC EDGAR · openFDA
last refreshed 1m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?